People Archives - Page 3 of 35 - Insights
Skip to Content MayoACCESS MayoLINK...
Aiming to advance understanding of hard-to-predict gastroenteropancreatic neuroendocrine tumors (GEP-NETs), Thermo Fisher Scientific joined forces with Mayo Clinic and BioPharma Diagnostics to validate and gain U.S. regulatory clearance of...
Frozen and on Time: Rapid Margin Assessment Helps Prevent Repeat Surgeries - Insights
A breakthrough in pathology, achieved more than a century ago (allegedly on a frozen window ledge in Rochester, Minnesota) has evolved into an innovative aspect of care at Mayo Clinic. Mayo is one of the only medical centers in the United...
Medical Drones: High Hopes, Grounded in Science - Insights
While online retailers experiment with drones as a way to swiftly deliver consumer purchases, laboratory medicine physicians and scientists have a lifesaving goal: using drones to rapidly deliver laboratory specimens.
Building a Scientific Collaborative Space - Insights
Combining innovative Mayo Clinic laboratories with medical businesses and creative start-up companies will help Rochester—and benefit patients.
What's New in Health Care Reform: Jan. 9 - Insights
Top highlights include: new research shows sugar substitutes are not healthier than real sugar, how light therapy helps Minnesotans during winter, what you must know about Parkinson's disease, new law requires hospitals post prices online,...
Lessons from Leaders: Who Let the DOGs Out? - Insights
Andy Cousin, FACHE, Director of Product Management and Marketing, interviews Amy Clayton, M.D., Division Chair of Anatomic Pathology at Mayo Clinic, about "disease-oriented groups," which are multidisciplinary teams formed to establish a...
Winter Activities: Safety Tips - Insights
Here in Minnesota, we have entered into the time of year that is either loved or hated by Minnesotans: winter. In honor of Winter Hazard Awareness Week, November 6–10, Pat Hlavka, CSP, Safety Coordinator at Mayo Clinic, suggests resources...
Lab discoveries fuel updates for autoimmune movement disorders test - Insights
Mayo Clinic Laboratories expanded movement disorders panel better identifies autoimmune conditions. Four recently identified biomarkers — septin-5, septin-7, neurochondrin, and adaptor protein-3B2 — have been added to the panel, and all...
Transforming clinical practice and changing outcomes for brain tumor patients - Insights
The genetic variability of glioma, and its more advanced relative glioblastoma, has made genetic testing to identify biomarkers associated with prognosis and treatment effectivity an integral component of care plan development. However, the...